B2B Timeline

Explore key milestones in the Bench to Bassinet Program, from the beginning of CHD GENES enrollment through the launch of B2B CHANGE.

B2B CHANGE

2026

B2B CHANGE Grant Started

The B2B Congenital Heart disease Advancing New understanding in Genomics (CHANGE) Grant started.

Cycle 3: 2020–2025

2025

CHD GENES Enrollment Concludes

CHD GENES closed to new participant enrollment, and Cycle 3 enrollment was completed.

View 2025 details
1,054 Cycle 3 probands
774 Cycle 3 relatives
14,171 Cumulative probands
18,968 Cumulative relatives
  • Cycle 3 enrollment was completed across nine sites.
  • Fourth round of CDDRC-only Scholars.
  • Return of Genetic Results, Round 2.
  • Gabriella Miller Kids First X01 awarded to Bruce Gelb, MD: Expanding our understanding of the role of noncoding variation causing congenital heart defects.
  • Gabriella Miller Kids First X01 awarded to Bruce Gelb, MD: Kids First X01 Long-Read Sequencing Pilot: Structural Heart and Other Defects.
  • Large-scale analysis of the genetic causes of CHD identified new genetic variants associated with CHD, including variants new to the affected individual and variants inherited from a parent.

Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genes 

2024

Third Scholars Cohort and New Study Activities

The third cohort of PCGC/CDDRC Scholars began, and additional study activities expanded opportunities for ongoing research.

View 2024 details
  • Third cohort of PCGC/CDDRC Scholars.
  • Brain and Genes Protocol closed, allowing for ongoing analyses of de-identified data.
  • Patient/parent reported Clinical Information and Adaptive Functioning study.
  • Two auxiliary sites were added: University of Michigan and Children’s Healthcare of Atlanta.

2023

Second Scholars Cohort and Brain and Genes Publication

The second cohort of PCGC/CDDRC Scholars began, and the CHD Brain and Genes analysis was published.

View 2023 details

2022

First PCGC/CDDRC Scholars Cohort

The first cohort of Pediatric Cardiac Genomics Consortium and Cardiovascular Developmental Biology Data Resource Center Scholars began.

2021

First EMR Extraction Data Received

The first electronic medical record extraction data was received from all active sites.

View 2021 details

Gabriella Miller Kids First X01 awarded to Bruce Gelb, MD: Expanding our understanding of the role of noncoding variation causing congenital heart defects.

2020

Cycle 3 Begins

Enrollment continued at remaining active sites, while the program’s focus shifted to longitudinal data collection from the existing cohort.

View Cycle 3 details

Longitudinal data sources included electronic medical records, echocardiogram imaging, the Society for Thoracic Surgery database, the National Death Index, and the MRI Core.

Remaining active sites included Columbia University, Mount Sinai, Yale University, Children’s Hospital Boston, Children’s Hospital of Los Angeles, Brigham and Women’s Hospital, and University of Utah.

Cycle 2: 2016–2020

2020

Cycle 2 Enrollment Completed

Cycle 2 enrollment was completed across 11 sites.

View Cycle 2 enrollment details
3,200 Cycle 2 probands
4,918 Cycle 2 relatives
13,117 Cumulative probands
18,194 Cumulative relatives

Gabriella Miller Kids First X01 awarded to Nicole Weaver, MD: Genetic diagnoses in a cohort of individuals with valvar pulmonary stenosis (PCGC ancillary study).

2019

Return of Genetic Results

Return of Genetic Results, Round 1.

2018

CHD Brain and Genes Enrollment Completed

Enrollment was completed with 196 participants.

View 2018 details

Gabriella Miller Kids First X01 awarded to Christine Seidman, MD: Germline Mutations in CHD.

2017

Large-Scale Analysis of Genetic Causes of CHD

A large-scale analysis identified shared genetic contributions to congenital heart disease, neurodevelopmental disabilities, and extracardiac congenital anomalies.

View related publication

2016

Cycle 2 Begins

Cincinnati Children’s Hospital Medical Center took over as the Administrative Coordinating Center and Data Management Coordinating Center.

View 2016 details
  • B2B partnered with the National Institute of Child Health and Human Development to develop the CHD Brain and Genes sub-study.
  • The sub-study was implemented by Jane Newburger, MD, and Eileen King, PhD, to study brain MRI and complete neurodevelopmental assessments on a subset of CHD GENES participants.
  • Gabriella Miller Kids First X01 awarded to Christine Seidman, MD: Discovery of De Novo and Inherited Mutations that Cause Prevalent Birth Defects.
Cycle 1: 2010–2015

2015

Cycle 1 Enrollment Completed

Cycle 1 enrollment was completed across 10 sites.

View 2015 details
9,917 Cycle 1 probands
13,276 Cycle 1 relatives
  • Gabriella Miller Kids First X01 awarded to Christine Seidman, MD: Discovery of the Genetic Basis of Structural Heart and Other Birth Defects.
  • An early paper on CHD causation identified new genes.

De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies 

2010

CHD GENES Enrollment Begins

The Administrative Coordinating Center was NERI/HealthCore/Carelon, and CHD GENES enrollment began at active sites.

View 2010 active sites

Active sites included Columbia University, Mount Sinai, Yale University, Children’s Hospital Boston, Children’s Hospital of Philadelphia, Children’s Hospital of Los Angeles, Brigham and Women’s Hospital, University of Rochester, Cohen Children’s Medical Center, and University College London.

Enrolling PCGC Sites

Site participation changed across program cycles.

View Site Participation
Site NamePrincipal Investigator(s)Participating Cycle
Columbia UniversityWendy Chung, MD
Yufeng Shen, PhD
Cycle 1-3
Mount SinaiBruce Gelb, MDCycle 1-3
Yale UniversityMartina Brueckner, MD
Peter Gruber, MD
Cycle 1-3
Boston Children's HospitalJane Newburger, MD
Amy Roberts, MD
Cycle 1-3
Brigham and Women's HospitalChristine Seidman, MDCycle 1-3
Children's Hospital of PhiladelphiaBetsy Goldmuntz, MDCycle 1-2
University of UtahMarti Tristani, MDCycle 2-3
Children's Hospital of Los AngelesRick Kim, MD
Shuo Wang, MD
Cycle 1-3
University of RochesterGeorge Porter, MDCycle 2
Gladstone / University of California, San FranciscoDeepak Srivastava, MDCycle 2
Stanford UniversityDan Bernstein, MDCycle 2
Cohen Children's Medical CenterDorota Gruber, PhDCycle 1
University College LondonJohn Deanfield, MD
Alessandro Giardini, MD
Cycle 1